Last reviewed · How we verify

ICG-guided bowel perfusion assessment — Competitive Intelligence Brief

ICG-guided bowel perfusion assessment (ICG-guided bowel perfusion assessment) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Surgical imaging agent. Area: Surgery / Gastroenterology.

phase 3 Surgical imaging agent Surgery / Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

ICG-guided bowel perfusion assessment (ICG-guided bowel perfusion assessment) — Leiden University Medical Center. ICG (indocyanine green) fluorescence imaging enables real-time visualization of bowel perfusion during surgery to assess tissue viability and prevent anastomotic complications.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ICG-guided bowel perfusion assessment TARGET ICG-guided bowel perfusion assessment Leiden University Medical Center phase 3 Surgical imaging agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Surgical imaging agent class)

  1. Leiden University Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ICG-guided bowel perfusion assessment — Competitive Intelligence Brief. https://druglandscape.com/ci/icg-guided-bowel-perfusion-assessment. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: